Synta to fund operations with $35 million stock offering

04/18/2011 | Mass High Tech (Boston)

Synta Pharmaceuticals pulled in $35 million in a stock placement to support its research and development efforts, manufacturing operations and other corporate functions. The biopharmaceutical firm also secured a $2 million loan that it will use to buy laboratory tools to test drug candidates for cancer and chronic inflammatory conditions.

View Full Article in:

Mass High Tech (Boston)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations